ITK and B-cell chronic lymphocytic leukemia: To assess the long-term in vivo effects of ITK deletion on CLL-CAR-T cells, we employed a CLL mouse model using NPG mice injected intravenously with MEC1 tumor cells, followed by infusion with ITK-KO or nt-KO CLL-CAR-T cells (Figure 8A).